Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women

Completed 61 enrolled University of Pittsburgh Society of Family Planning · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

This study is designed to evaluate if self-inserted intravaginal 2% lidocaine gel is effective at decreasing pain during intrauterine device insertion in nulliparous women.

Timeline

Start: 2012-06
Primary completion: 2013-05
Completion: 2013-05

Outcome

Missed primary endpoint

paper For nulliparous women, self-administered vaginal lidocaine gel does not reduce pain with IUD insertion PMID 27500351 ↗

Publications

Rapkin RB, Achilles SL, Schwarz EB, Meyn L, Cremer M, Boraas CM, Chen BA. Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial. Obstet Gynecol. 2016 Sep;128(3):621-8. doi: 10.1097/AOG.0000000000001596.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lidocaine	Other / unclassified	2 %	Other
Subject	Lidocaine	Other / unclassified	4 ml	Other

Indications

No indication recorded.